Botensilimab Antibody
Botensilimab (AGEN 1181) is a humanized anti-CTLA-4 monoclonal antibody designed to potentiate both innate and adaptive antitumor immunity. It is being investigated in preclinical and clinical research for its enhanced immunomodulatory functions in various solid tumors.
Product Specifications
Product Name Alternative
AGEN 1181, AGEN1181
Target
Immunology/Inflammation related
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
6.38 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
144.52 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![2-{[ (tert-Butoxy) carbonyl]amino}-2-phenylpropanoic acid](https://cdn.genprice.uk/genprice/uk/genprice3.webp)
QQA40140-01 250 mg
2-{[ (tert-Butoxy) carbonyl]amino}-2-phenylpropanoic acid
Sign In for Pricing
View Details QQA40140-02 2.5 g
2-{[ (tert-Butoxy) carbonyl]amino}-2-phenylpropanoic acid
Sign In for Pricing
View Details MBS081815-04 10x 96 Well
Horse Kruppel Like Factor 4, Gut ELISA Kit
Sign In for Pricing
View Details